6-tetra-O-acetyl-β-D-galactopyranosly)-L-glycerol. This compound was converted into the crystalline 3-O-(2,3,4-tri-O-benzyl-β-D-galactopyranosyl)-L-glycerol, which was used as an intermediate for the synthesis of the title compounds. 3-O-(2,3,4-Tri-O-benzyl-β-D-galactopyranosyl)-L-glycerol is also a potential intermediate for the syntheses of ‘polygalactosyl diglycerides’ which are the serologically active
将1,2-二-O-苄基-L-
甘油(通过3 - O-烯丙基-1,2-二-O-苄基-L-
甘油通过新方法制备)糖基化以得到1,2-二- O-苄基-3- O-(2,3,4,6-四-O-乙酰基-β - D-
吡喃半
乳糖醛)-L-
甘油。将该化合物转化为结晶的3 - O-(2,3,4-三-O-苄基-β - D-
吡喃并
吡喃糖基)-L-
甘油,将其用作合成标题化合物的中间体。3- ø - (2,3,4-三- ö-苄基-β - D-
吡喃半
乳糖基)-L-
甘油也是合成``聚半
乳糖基
甘油二酸酯''的潜在中间体,``聚半
乳糖基
甘油二酸酯''是肺炎支原体
糖脂的血清学活性成分。制备了1,2-双-O-(2-甲基烯丙基)-L-
甘油,并尝试将其在β-链中与2,3,4-三-O-苄基-6- O-(丁-2-烯基)-α- d -galactopyranosyl酰
氯[由选自烯丙基-6-新途径制备ø - (丁-2-烯基)-α- d -gala